Joinn Laboratories(China)Co.,Ltd.
603127
Κατάταξη σε μετοχές
#3812
Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of... Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of preclinical and non-clinical services to clients across the United States, China, and other international regions. The company's business is organized into three core operational areas. Its Non-Clinical Studies Services segment focuses on drug safety assessment, drug metabolism and pharmacokinetics analysis, and pharmacology and efficacy investigations. The Clinical Trial and Related Services division offers contract research organization (CRO) support for clinical trials, co-manages Phase I clinical research units, and provides bioanalytical services. Furthermore, the Sales of Research Models segment is involved in the design, production, breeding, and distribution of various research models, including non-human primates and rodents. Beyond these offerings, Joinn Laboratories also provides investment management and cell-based assay (CBA) services. Founded in 1995, the company is headquartered in Beijing, China.
Τιμή μετοχής
$6.82
Κεφαλαιοποίηση
$4.30B
Αλλαγή (1 ημέρα)
-6.30%
Αλλαγή (1 έτος)
48.79%
Χώρα
CN
Εμπόριο Joinn Laboratories(China)Co.,Ltd. (603127)
Κατηγορία
Healthcare
Δείκτης P/S για Joinn Laboratories(China)Co.,Ltd. (603127)
Δείκτης P/S στις October 2026 TTM: 16.96
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή μετοχής της Joinn Laboratories(China)Co.,Ltd., ο τρέχων δείκτης P/S (TTM) είναι 16.96. Στο τέλος του 2024, ο δείκτης ήταν 6.10.
Ιστορικό P/S για την Joinn Laboratories(China)Co.,Ltd. από 2012 έως 2026
Δείκτης P/S στο τέλος κάθε έτους
| Έτος | P/S Ratio | Αλλαγή |
|---|---|---|
| 2026 (TTM) | 16.96 | 7.83% |
| 2025 | 15.73 | 157.67% |
| 2024 | 6.10 | -15.66% |
| 2023 | 7.24 | -47.54% |
| 2022 | 13.80 | -50.84% |
| 2021 | 28.06 | 29.16% |
| 2020 | 21.73 | 49.50% |
| 2019 | 14.53 | 9.31% |
| 2018 | 13.30 | 3.24% |
| 2017 | 12.88 | 181.31% |
| 2016 | 4.58 | -14.49% |
| 2015 | 5.35 | -10.22% |
| 2014 | 5.96 | -23.01% |
| 2013 | 7.75 | -30.15% |
| 2012 | 11.09 | 0.00% |
Δείκτης P/S για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | P/S Ratio | Διαφορά P/S Ratio | Χώρα |
|---|---|---|---|
| 5.29 | -68.79% |
US
|
|
| 6.43 | -62.11% |
US
|
|
| 21.32 | 25.68% |
US
|
|
| 6.53 | -61.51% |
CN
|
|
| 6.80 | -59.91% |
US
|
